4//SEC Filing
Shendelman Shoshana 4
Accession 0000950170-24-097309
CIK 0001697532other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 7:01 PM ET
Size
14.8 KB
Accession
0000950170-24-097309
Insider Transaction Report
Form 4
Shendelman Shoshana
DirectorPresident and CEO10% Owner
Transactions
- Gift
Common Stock
2024-08-05+747,886→ 747,886 total(indirect: See footnote) - Sale
Common Stock
2024-08-12$5.98/sh−300,000$1,794,000→ 5,167,853 total - Sale
Common Stock
2024-08-13$6.18/sh−357,423$2,208,874→ 4,810,430 total - Sale
Common Stock
2024-08-14$5.93/sh−119,591$709,175→ 4,690,839 total - Gift
Common Stock
2024-08-05−747,886→ 0 total(indirect: See footnote)
Holdings
- 1,492,094(indirect: See footnote)
Common Stock
- 88,397(indirect: See footnote)
Common Stock
- 290,280(indirect: See footnote)
Common Stock
Footnotes (8)
- [F1]Through a grantor retained annuity trust. Upon termination of the trust, 747,886 shares of the issuer's common stock were distributed to a family trust controlled by the reporting person. The remaining shares were distributed to the reporting person and continue to be reported in this Form 4 as directly owned.
- [F2]Through a family trust controlled by the reporting person.
- [F3]Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.57 to $6.205, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.82 to $6.39, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F5]Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.825 to $6.265, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F6]Through a family trust controlled by the reporting person.
- [F7]Through a family trust controlled by the reporting person.
- [F8]Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.
Documents
Issuer
Applied Therapeutics, Inc.
CIK 0001697532
Entity typeother
Related Parties
1- filerCIK 0001775490
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 7:01 PM ET
- Size
- 14.8 KB